Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioanna Andreadou, Evangelos Terpos · 2023
Read Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights by Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioanna Andreadou, Evangelos Terpos (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10743961.txt.
Description
Anastasios Tentolouris and co-authors review a blood condition and its link to heart disease in a 2023 paper. The condition, shortened to MGUS, is a pre cancer state. A faulty clone of plasma cells makes a single type of antibody, found at low levels in the blood. The clone grows into blood cancer in about one percent of patients per year. Beyond that risk, new data tie the condition to heart and vessel disease.
The review weighs possible mechanisms. The abnormal protein may harm vessel linings directly. Related effects include vessel calcification, autoantibodies, and rare protein disorders that chill or clot the blood. Genetic faults may play a part as well. The authors suggest that patients with this condition get regular heart risk checks alongside their blood follow up, to head off severe heart complications.
Catalog record
| CREATOR | Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioanna Andreadou, Evangelos Terpos |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |